Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: South Korea Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20061
20074
20081
20094
20101
20112
20125
20134
20143
20153
20162
20174
20185
20194
202110
20228
20232
20243
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Active, not recruiting16
Recruiting13
Terminated11
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Eli Lilly and Company9
Novartis Pharmaceuticals6
Pfizer5
Sanofi4
Samsung Medical Center3
AbbVie2
Amgen2
Australasian Gastro-Intestinal Trials Group2
BeiGene2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis76
Breast Neoplasms25
Neoplasms14
Carcinoma, Non-Small-Cell Lung10
Carcinoma6
Adenocarcinoma4
Breast Diseases4
Colorectal Neoplasms4
Neoplasms by Site4
Prostatic Neoplasms4

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.